What We're Reading: Page 93
Industry reads hand-picked by our editors
Aug 14, 2023
-
AP news
Insurers won’t cover new Alzheimer’s treatment for some customers
-
Stat
FOP patients plead for FDA approval of drug despite muddled data
-
Fierce Pharma
Another round of layoffs hits BMS, with 100+ people impacted after earnings miss
-
The Wall Street Journal
Ozempic Settles the Obesity Debate: It’s Biology Over Willpower
Aug 11, 2023
Aug 10, 2023
Aug 09, 2023
-
Bloomberg
The Weight-Loss Drug Frenzy Is Outrunning the Company Behind It
-
Fierce Pharma
Mirati parts ways with CEO, lays out new Krazati-Keytruda trial plan in lung cancer
-
The Wall Street Journal
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
-
MIT Technology Review
After 25 years of hype, embryonic stem cells are still waiting for their moment
Aug 08, 2023
-
The Atlantic
There’s a New Drug for Eczema—Actually, a Ton of New Drugs
-
Financial Times
Meta disbands protein-folding team in shift towards commercial AI
-
Fierce Biotech
20 years in, Singapore still searches for its biotech success story
-
Bloomberg
Elon Musk’s Neuralink Raises $280 Million to Develop Brain Implants
Aug 07, 2023
Aug 04, 2023
-
Bloomberg
Murder, Money and the Battle for a Pharmaceutical Empire
-
STAT
ProMED, an early warning system on disease outbreaks, appears near collapse
-
Reuters
Mesoblast shares tank after US FDA rejects cell therapy for children
-
The Wall Street Journal
AI-Generated Data Could Be a Boon for Healthcare—If Only It Seemed More Real
Previous
